RecruitingNCT06535503
Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction (STEMI) Patients With Cardiogenic Shock at Abu Dhabi City
Sponsor
Abu Dhabi Health Services Company
Enrollment
400 participants
Start Date
Jul 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age more than 18.
- STEMI complicated by cardiogenic shock.
- Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
- Patient admitted between January 2019 to March 2024.
Exclusion Criteria5
- Age less than 18.
- Shock patient not related to Myocardial infarction.
- NSTEMI-related cardiogenic shock.
- Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
- Patient not admitted between January 2019 to March 2024.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06535503
Related Trials
Abiomed Impella RT-DAQ - Observational Study
NCT063080554 locations
Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)
NCT075972911 location
BEAT-SHOCK Registry
NCT076436101 location
OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science
NCT076191441 location
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
NCT0635359423 locations